Publications Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: a model based analysis
Publications Economic value of lost productivity attributable to human papillomavirus cancer mortality in the United States
Publications Potential public health impact of a neisseria meningitidis A, B, C, W, and Y pentavalent vaccine in the United States
Publications Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States
Publications Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis
Publications Budget impact analysis of introducing a non-reconstituted, hexavalent vaccine for pediatric immunization in the United Kingdom
Publications What did time tell us? A comparison and retrospective validation of different survival extrapolation methods for immuno-oncologic therapy in advanced or metastatic renal cell carcinoma
Publications Direct medical costs associated with treatment nonpersistence in patients with higher-risk myelodysplastic syndromes receiving hypomethylating agents: a large retrospective cohort analysis
Publications Mortality prediction of the CHA 2 DS 2-VASc score, the HAS-BLED score, and their combination in anticoagulated patients with atrial fibrillation
Publications Under-use of hypomethylating agents in patients with higher-risk myelodysplastic syndrome in the United States: a large population-based analysis